Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
culmerciclib (TQB3616)
i
Other names:
TQB3616, TQB-3616, TQB 3616
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Sino Biopharm
Drug class:
CDK2/4/6 inhibitor
Related drugs:
‹
RGT-419B (2)
PF-06873600 (1)
PF-07224826 (0)
SYH2043 (0)
NUV-422 (0)
RGT-419B (2)
PF-06873600 (1)
PF-07224826 (0)
SYH2043 (0)
NUV-422 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
ER positive
HER2 Negative Breast Cancer
ER positive
HER2 Negative Breast Cancer
TQB3616
Sensitive: C2 – Inclusion Criteria
TQB3616
Sensitive
:
C2
TQB3616
Sensitive: C2 – Inclusion Criteria
TQB3616
Sensitive
:
C2
HER-2 positive
HER2 Positive Breast Cancer
HER-2 positive
HER2 Positive Breast Cancer
TQB3616
Sensitive: D – Preclinical
TQB3616
Sensitive
:
D
TQB3616
Sensitive: D – Preclinical
TQB3616
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.